Gut-immune connection could boost immunotherapy effectiveness in recurrent ovarian cancer

A study led by Roswell Park Comprehensive Cancer Center provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian cancer.